The Challenge
Curia retained PharmaBioSource as its exclusive consultant to divest its sterile injectables manufacturing site and contract development and manufacturing business in León, Spain.
The Solution
PharmaBioSource marketed the site and CDMO business to strategic acquirers.
Services provided by the PharmaBioSource team:
- Benchmark valuation
- Buyer target identification and engagement
- Creation of the Confidential Information Memorandum (CIM)
- Data room development
- Due diligence support
The Results
PharmaBioSource identified LSNE, a U.S. sterile drug product CDMO, as the acquirer. LSNE acquired the León site to establish its first presence in Europe.
What We Did
Sell-Side Advisory
Facility Divestiture